Related Experiment Video
Updated: Jul 19, 2026
09:01
Extraction and Quantification of Soluble, Radiolabeled Inositol Polyphosphates from Different Plant Species using SAX-HPLC
Published on: June 26, 2020
Protection against cancer by dietary IP6 and inositol
Ivana Vucenik1, AbulKalam M Shamsuddin
1Department of Pathology, University of Maryland School of Medicine, MD 21201, USA. ivucenik@umaryland.edu
Nutrition and Cancer
|October 19, 2006
Summary
Inositol hexaphosphate (IP(6)), a plant-derived compound, shows significant promise in cancer prevention and therapy. It exhibits anticancer actions by arresting cell cycles, inducing differentiation, and enhancing immunity, with potential to improve chemotherapy outcomes.
Area of Science:
- Biochemistry
- Cell Biology
- Nutritional Science
Background:
- Inositol hexaphosphate (IP(6)) is a naturally occurring polyphosphorylated carbohydrate found in plant sources and mammalian cells.
- IP(6) plays a role in cellular functions like signal transduction, proliferation, and differentiation.
- It is recognized for its antioxidant properties and potential health benefits, including cancer prevention.
Purpose of the Study:
- To review the efficacy and molecular mechanisms of inositol hexaphosphate (IP(6)) as a dietary agent.
- To highlight IP(6)'s role in cancer prevention and control of tumor growth, progression, and metastasis.
- To discuss other health benefits of IP(6), such as immune enhancement and prevention of pathological calcification.
Main Methods:
- Review of existing literature on inositol hexaphosphate (IP(6)) efficacy and mechanisms.
- Analysis of experimental models demonstrating anticancer actions of IP(6).
- Inclusion of preliminary human studies on IP(6) and inositol in cancer therapy.
Main Results:
- IP(6) is rapidly absorbed and dephosphorylated intracellularly, affecting signal transduction pathways and leading to cell cycle arrest.
- IP(6) demonstrated significant anticancer activity in experimental models, reducing proliferation and inducing differentiation of malignant cells.
- Enhanced immunity and antioxidant properties of IP(6) contribute to tumor cell destruction.
Conclusions:
- IP(6) exhibits potent anticancer effects through multiple mechanisms, including cell cycle arrest and differentiation induction.
- Preliminary human studies suggest IP(6) and inositol can enhance chemotherapy, control metastasis, and improve quality of life.
- IP(6) and inositol are safe, well-absorbed, and abundant in the diet, supporting their role in cancer prevention and therapy, warranting clinical trials.
Related Concept Videos
02:59Cancer Prevention
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
02:59Cancer Prevention
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
02:34Inhibition of Cdk Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
02:34Inhibition of CDK Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
01:42Phosphoinositides and PIPs
Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
01:31The Intrinsic Apoptotic Pathway
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...